QuitStart + LTQ-H App for Smoking Cessation in HIV

(QMH Trial)

This trial tests two different smartphone apps, QuitStart and Learn to Quit-HIV (LTQ-H), to help people with HIV quit smoking. Participants will use one of the apps and receive nicotine patches and gum to assist with quitting. The study aims to determine which app is most effective for smoking cessation among people living with HIV. Those who have smoked daily for the last 30 days, are living with HIV, and want to quit smoking might be a good fit for this trial. Participants will check in through video calls and provide feedback over approximately six months. As an unphased trial, this study offers a unique opportunity to contribute to research that could enhance smoking cessation strategies for people with HIV.

The trial does not specify if you need to stop taking your current medications. However, if you are on any medication that could affect your safety, the study team will decide if you can participate.

Research shows that the Learn to Quit-HIV (LTQ-H) app is being developed to help people with HIV quit smoking. Previous studies have used similar apps that offer behavioral techniques and real-time feedback to assist in smoking cessation. Users generally find these apps easy to handle, with no major side effects reported. Since apps like LTQ-H focus on behavioral support, they pose a low risk for physical side effects.

The QuitStart app is another evidence-based tool designed for everyone. Studies have shown that similar digital tools for quitting smoking are safe and easy to use. They provide support through practical advice and motivational content, with no known physical risks.

Researchers are excited about the Learn to Quit-HIV (LTQ-H) App because it's specially designed for people living with HIV who want to quit smoking. Unlike standard smoking cessation tools like nicotine replacement therapy or general apps such as QuitStart, LTQ-H tailors its support to the unique health needs and challenges faced by people with HIV. It's a digital therapeutic that offers personalized strategies, making it a potentially more effective option for this specific population. This targeted approach is what sets it apart from more generic smoking cessation options.

This trial will compare the effectiveness of two smoking cessation apps. Research shows that the Learn to Quit-HIV (LTQ-H) app, available to participants in this trial, is designed to help people with HIV quit smoking using behavioral techniques. This app employs Acceptance and Commitment Therapy, which aids users in managing cravings and maintaining motivation. Early studies suggest that the app's interactive features and real-time feedback could be effective for this group.